Battelle Awarded 10.1M CBRN Support Contract

June 28, 2016

The U.S. Department of Defense has recently awarded a notable contract related to the field of chemical, biological, radiological and nuclear (CBRN) equipment or life science research of interest for potential applications [Read more]

DoD Seeks Medical Countermeasure Manufacturing

June 6, 2016

The U.S. Department of Defense (DoD) is conducting market research to identify vaccine developers who have advanced manufacturing platforms which are adaptable to incorporating known antigens for use as a prophylaxis countermeasure [Read more]

RFI – Bioscavenger Medical Countermeasures

January 29, 2016

The U.S. Department of Defense is seeking information from organizations on their capability to support advanced development of human butyrylcholinesterase (HuBChE) as a medical countermeasure. Overseen by the Joint Product Manager – [Read more]

BioMARC Helps Advance Biodefense Vaccines for DoD

January 21, 2016

Colorado State University’s Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) has been awarded a 10-month, $4.6 million contract to help develop and manufacture new vaccines to fight Western, Eastern and Venezuelan Equine [Read more]

1 2 3 10